Elanco Animal Health
ELAN
479 hedge funds and large institutions have $13.5B invested in Elanco Animal Health in 2021 Q4 according to their latest regulatory filings, with 89 funds opening new positions, 165 increasing their positions, 149 reducing their positions, and 53 closing their positions.
68% more first-time investments, than exits
New positions opened: 89 | Existing positions closed: 53
11% more repeat investments, than reductions
Existing positions increased: 165 | Existing positions reduced: 149
6% more funds holding
Funds holding: 452 → 479 (+27)
1.48% more ownership
Funds ownership: 98.99% → 100.47% (+1.5%)
10% less capital invested
Capital invested by funds: $14.9B → $13.5B (-$1.46B)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
67% less call options, than puts
Call options by funds: $31.8M | Put options by funds: $96.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$578M |
| 2 |
D.E. Shaw & Co
New York
|
+$71.1M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
+$64.3M |
| 4 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$61.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$52.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$389M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$96M |
| 3 |
Korea Investment Corp
Seoul,
South Korea
|
-$69.2M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$64M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$44.6M |
ELAN Hedge Fund Activity: Q4 2021 in Review
479 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q4 2021, worth a combined $13.5B — down 9.8% from $14.9B a quarter earlier.
Buyers outnumbered sellers: 89 funds opened new ELAN positions and 53 closed out — a net gain of 36 holders — while 165 added to existing stakes and 149 trimmed.
The largest buyer was Dodge & Cox, adding an estimated $578M. The largest seller was T. Rowe Price Associates, cutting an estimated $389M.
- 479 institutional investors held Elanco Animal Health (ELAN) as of Q4 2021, up from 452 in Q3 2021.
- Funds reported $13.5B of Elanco Animal Health stock for Q4 2021, down 9.8% quarter-over-quarter.
- 89 funds opened new Elanco Animal Health positions in Q4 2021 and 53 closed out, a net change of +36 holders.
- The largest Elanco Animal Health buyer in Q4 2021 was Dodge & Cox, an estimated $578M added.
- The largest Elanco Animal Health seller in Q4 2021 was T. Rowe Price Associates, an estimated $389M sold.
Based on aggregated 13F filings for Q4 2021.